nicotine has been researched along with Anxiety Disorders in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (21.21) | 18.7374 |
| 1990's | 5 (15.15) | 18.2507 |
| 2000's | 8 (24.24) | 29.6817 |
| 2010's | 8 (24.24) | 24.3611 |
| 2020's | 5 (15.15) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, SI; Azzouz, N; Cather, C; Evins, AE; Foulds, J; Hameed, A; Hammett, E; Hrabovsky, S; Krebs, NM; Lester, C; Liao, J; Modesto, J; Muscat, JE; Pachas, G; Reinhart, L; Richie, JP; Trushin, N; Veldheer, S; Wasserman, E; Yingst, J; Zhu, J | 1 |
| Cassidy, R; DeAtley, T; Harrison, A; Higgins, ST; Kuo, C; Tidey, JW | 1 |
| Alexander, AC; Businelle, MS; Hébert, ET; Kendzor, DE; Olurotimi, O; Ra, CK | 1 |
| Laviolette, SR | 1 |
| Blendy, JA; Brynildsen, JK; Jin, S; Kim, SF; Lee, BG; Perron, IJ | 1 |
| D'Souza, MS; Norman, H; Rorabaugh, BR; Seeley, SL; Sprague, L | 1 |
| Robinson, MJF; Russell, TI | 1 |
| Baker, TB; Cook, JW; Piper, ME; Schlam, TR; Smith, SS | 1 |
| Gould, TJ; Kutlu, MG | 1 |
| Muheim, L | 1 |
| Allen, SI; Azzouz, N; Cather, C; Evins, AE; Foulds, J; Hameed, A; Hammett, E; Hrabovsky, S; Krebs, NM; Liao, J; Modesto, J; Muscat, JE; Pachas, GN; Richie, J; Veldheer, S; Yingst, J; Zhu, J | 1 |
| Arends, MA; Fowler, CD; Kenny, PJ | 1 |
| Baker, TB; Bittrich, AA; Brown, JL; Fiore, MC; Fleming, MF; Leitzke, CJ; Piper, ME; Schlam, TR; Smith, SS; Zehner, ME | 1 |
| Baker, TB; Cook, JW; Jorenby, DE; Piper, ME; Schlam, TR | 1 |
| Gatch, MB; Jung, ME; Lal, H | 1 |
| FORSGREN, E | 1 |
| Cornuz, J; Khazaal, Y; Zullino, D | 1 |
| Aso, E; Balerio, GN; Maldonado, R | 1 |
| González-Cuevas, G; López-Moreno, JA; Navarro, M | 1 |
| Gulliver, SB; Kamholz, BW; Morissette, SB; Tull, MT; Zimering, RT | 1 |
| Mineur, YS; Picciotto, MR; Vieyra-Reyes, P | 1 |
| Andreski, P; Breslau, N; Kilbey, MM | 3 |
| Dursun, SM; Kutcher, S | 1 |
| Cheeta, S; File, SE; Kenny, PJ | 1 |
| Andreski, P; Breslau, N; Kilbey, M | 1 |
| Roy-Byrne, PP; Uhde, TW | 1 |
| Dilsaver, SC | 1 |
| Cohen, RM; Mueller, ER; Murphy, DL; Newhouse, PA; Sunderland, T; Tariot, PN; Thompson, K; Weingartner, H | 1 |
| Foulks, E; Maany, I; Woody, G | 1 |
| Hughes, JR | 1 |
| Brodsky, L | 1 |
8 review(s) available for nicotine and Anxiety Disorders
| Article | Year |
|---|---|
Molecular and neuronal mechanisms underlying the effects of adolescent nicotine exposure on anxiety and mood disorders.
Topics: Adolescent; Adolescent Behavior; Animals; Anxiety Disorders; Brain; Electronic Nicotine Delivery Systems; Humans; Mood Disorders; Nicotine; Tobacco Use; Vaping | 2021 |
Nicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders.
Topics: Animals; Anxiety Disorders; Fear; Humans; Learning; Memory; Nicotine | 2015 |
Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Animals, Genetically Modified; Anxiety Disorders; Arousal; Comorbidity; Depressive Disorder; Genotype; Humans; Mice; Mice, Knockout; Nicotine; Phenotype; Receptors, Nicotinic; Reward; Schizophrenia; Signal Transduction; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments.
Topics: Animals; Anxiety Disorders; Calcium Channels, L-Type; Discrimination, Psychological; Drug Interactions; GABA Antagonists; GABA-A Receptor Antagonists; Glycine Agents; Models, Animal; Nicotine; Pentylenetetrazole; Pituitary-Adrenal System; Receptors, GABA-A; Receptors, Glycine; Receptors, Nicotinic; Receptors, Serotonin; Serotonin; Sex Factors; Strychnine; Substance Withdrawal Syndrome | 2002 |
Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships.
Topics: Anxiety; Anxiety Disorders; Humans; Nicotine; Prevalence; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research.
Topics: Acetylcholine; Anxiety Disorders; Dopamine; Ethics, Medical; Humans; Mental Disorders; Models, Neurological; Mood Disorders; Nicotine; Norepinephrine; Psychopharmacology; Receptors, Nicotinic; Schizophrenia; Serotonin; Smoking; Tourette Syndrome | 1999 |
Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anxiety Disorders; Disease Models, Animal; Hippocampus; Maze Learning; Nicotine; Rats; Septum of Brain; Serotonin Receptor Agonists | 2000 |
Exogenous factors in panic disorder: clinical and research implications.
Topics: Anxiety Disorders; Caffeine; Cocaine; Diet; Ethanol; Fear; Humans; Life Change Events; Marijuana Abuse; Nicotine; Nonprescription Drugs; Pain; Panic; Physical Exertion; Sleep Deprivation; Substance-Related Disorders | 1988 |
7 trial(s) available for nicotine and Anxiety Disorders
| Article | Year |
|---|---|
The effects of reduced nicotine content cigarettes on biomarkers of nicotine and toxicant exposure, smoking behavior and psychiatric symptoms in smokers with mood or anxiety disorders: A double-blind randomized trial.
Topics: Adult; Anxiety Disorders; Biomarkers; Cotinine; Hazardous Substances; Humans; Nicotine; Smokers; Smoking; Tobacco Products | 2022 |
Subjective experiences, contexts, and risk perceptions of very low nicotine content cigarettes and electronic cigarettes among people with depression and anxiety disorders who smoke.
Topics: Anxiety Disorders; Depression; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Products; Vaping | 2023 |
Anxiety Sensitivity and Distress Tolerance in Smokers: Relations With Tobacco Dependence, Withdrawal, and Quitting Success†.
Topics: Adolescent; Adult; Anxiety Disorders; Child; Ecological Momentary Assessment; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Smokers; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Varenicline; Young Adult | 2020 |
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Bupropion; Cohort Studies; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Nicotine; Smoking Cessation; Varenicline; Young Adult | 2016 |
A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
Topics: Adult; Anxiety Disorders; Biomarkers; Carbon Monoxide; Clinical Protocols; Cotinine; Double-Blind Method; Female; Humans; Male; Massachusetts; Mood Disorders; Nicotiana; Nicotine; Nicotinic Agonists; Nitrosamines; Oxidative Stress; Pennsylvania; Pyrenes; Pyridines; Smoke; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; United States; United States Food and Drug Administration; Young Adult | 2017 |
Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation.
Topics: Adult; Anxiety Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Motivation; Nicotine; Patient Selection; Psychiatric Status Rating Scales; Regression Analysis; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2010 |
Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.
Topics: Adolescent; Anxiety Disorders; Bupropion; Counseling; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Interview, Psychological; Logistic Models; Male; Nicotine; Nicotinic Agonists; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2011 |
18 other study(ies) available for nicotine and Anxiety Disorders
| Article | Year |
|---|---|
Subjective social status is indirectly associated with short-term smoking cessation through nicotine withdrawal symptoms.
Topics: Adult; Anxiety Disorders; Humans; Nicotine; Psychological Distance; Smoking Cessation; Substance Withdrawal Syndrome | 2021 |
Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Anxiety Disorders; Drug Evaluation, Preclinical; Enzyme Activation; Feeding Behavior; Gene Knockdown Techniques; Hippocampus; Male; Metformin; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Nerve Tissue Proteins; Nicotine; Ribonucleotides; Signal Transduction; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2018 |
Regulator of G protein signaling 2 differentially regulates nicotine-induced anxiolytic- and antidepressant-like effects in mice.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Behavior, Animal; Depression; Depressive Disorder; Maze Learning; Mice, Knockout; Nicotine; RGS Proteins | 2018 |
Effects of nicotine exposure and anxiety on motivation for reward and gambling-like cues under reward uncertainty.
Topics: Animals; Anxiety; Anxiety Disorders; Conditioning, Classical; Conditioning, Operant; Cues; Female; Gambling; Male; Motivation; Nicotine; Probability; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Uncertainty | 2019 |
[Nicotine poisoning and literary anxiety].
Topics: Anxiety; Anxiety Disorders; Humans; Nicotine; Smoking | 1959 |
[Are anxiety disorders associated to a particular addiction to smoking? Stress, anxiety and nicotine addiction].
Topics: Adaptation, Psychological; Anxiety Disorders; Arousal; Brain; Comorbidity; Humans; Nicotine; Risk Factors; Smoking; Stress, Psychological; Tobacco Use Disorder | 2004 |
Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice.
Topics: Analysis of Variance; Animals; Anxiety Disorders; Behavior, Animal; Dose-Response Relationship, Drug; Drug Antagonism; Drug Synergism; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Maze Learning; Mecamylamine; Mice; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Opioid | 2005 |
The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol.
Topics: Alcohol-Induced Disorders, Nervous System; Alcoholism; Animals; Anxiety Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Synergism; Male; Maze Learning; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Rimonabant; Secondary Prevention; Substance Withdrawal Syndrome; Sucrose | 2007 |
Voluntary oral nicotine intake in mice down-regulates GluR2 but does not modulate depression-like behaviors.
Topics: Administration, Oral; Animals; Anxiety Disorders; Behavior, Animal; Brain; Cyclic AMP Response Element-Binding Protein; Depressive Disorder; Down-Regulation; Glutamic Acid; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Motor Activity; Neural Pathways; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Receptors, AMPA; Reward; Synaptic Transmission; Tobacco Use Disorder; Ventral Tegmental Area; Volition | 2008 |
Vulnerability to psychopathology in nicotine-dependent smokers: an epidemiologic study of young adults.
Topics: Adult; Age Factors; Alcoholism; Anxiety Disorders; Comorbidity; Depressive Disorder; Female; Humans; Male; Mental Disorders; Nicotine; Personality Inventory; Psychiatric Status Rating Scales; Smoking; Substance-Related Disorders; Tobacco Use Disorder | 1993 |
Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults.
Topics: Adult; Alcoholism; Anxiety Disorders; Black or African American; Comorbidity; Depressive Disorder; Educational Status; Female; Humans; Male; Marriage; Nicotine; Severity of Illness Index; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders | 1992 |
Nicotine dependence, major depression, and anxiety in young adults.
Topics: Adult; Anxiety Disorders; Comorbidity; Confidence Intervals; Depressive Disorder; Female; Humans; Male; Nicotine; Odds Ratio; Severity of Illness Index; Substance-Related Disorders; Tobacco Use Disorder | 1991 |
Nicotine dependence in an urban population of young adults: prevalence and co-morbidity with depression, anxiety and other substance dependencies.
Topics: Adult; Anxiety Disorders; Black or African American; Depression; Education; Female; Humans; Male; Nicotine; Substance-Related Disorders; White People | 1990 |
Nicotine and panic attacks.
Topics: Anxiety Disorders; Fear; Humans; Nicotine; Panic; Smoking | 1987 |
Intravenous nicotine in a patient with Alzheimer's disease.
Topics: Alzheimer Disease; Anxiety Disorders; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Male; Middle Aged; Nicotine; Panic | 1986 |
Nicotine and panic attacks.
Topics: Animals; Anxiety Disorders; Chewing Gum; Drug Tolerance; Fear; Humans; Nicotine; Panic | 1987 |
Nicotine gum to treat panic attacks?
Topics: Anxiety Disorders; Chewing Gum; Fear; Humans; Nicotine; Panic; Smoking | 1986 |
Can nicotine control panic attacks?
Topics: Anxiety Disorders; Fear; Humans; Nicotine; Panic; Self Medication; Smoking | 1985 |